Dawn Halkuff Email & Phone Number

Florida, United States

Greater Chicago Area

Company: $110 million provider of commercial therapeutic products and a unique injection technology platform.Chair: Nominating/Governance Committee Member: Compensation Committee

Miami-Fort Lauderdale Area

• Company: 8-figure, private equity owned provider of consumer weight loss products & education services and manufacturer/contract manufacturer of protein-based food products and supplements.Lead development and.
• Presented and gained approval for strategic plan, rebuilt syndicate relationships, and negotiated new debt agreement between Board and lenders.
• Significantly reduced 6-year trend of annual revenue and EBITDA declines.
• Freed cash to create and pilot digital consumer lead generation program (social & paid media, search, advertising, call center) for Ideal Protein clinics. Model proved ability to scale.
• Faced new competition and consumer sentiment shift as semaglutide products were approved by the FDA for weight loss.
• Collaborated with court-appointed monitor, EY, to restructure company, maximize value, and continue to generate positive EBITDA and cash flow while company was offered for sale.

Miami-Fort Lauderdale Area

• Company: $87 million (2021) women’s health care and pharmaceutical company, (NASDAQ: TXMD).Led commercial strategy development and execution; built organization. Managed 200-person team, 6 directs, and 8-figure budget..
• Transformed a prescription prenatal vitamin company into a pharmaceutical company that competed successfully in $1+ billion markets.
• Developed and presented commercial strategy to Board, investors, lenders, and potential partners. Played key role in securing 9-figure term loan and preferred stock investors.
• Differentiated innovative, branded products in crowded, generic-dominated markets.
• Launched IMVEXXYTM, TXMD’s first pharmaceutical product, in 2018. Grew to $32 million, 37% of product revenue, in 2021.
• Launched ANNOVERATM and BIJUVATM in 2019. Grew to $38 million, 47% of product revenue, and $11 million, 12% of product revenue, respectively in 2021.

New York City Metropolitan Area

• Company: $53 billion, Fortune 100 consumer health care and biopharmaceutical company.Recruited to lead R&D and marketing for newly formed $2+ billion global wellness organization (consumer packaged goods). Reported to.
• Created and executed brand extension roadmap that closed projected revenue gaps.
• Established monthly innovation forum and governance process for project approvals, tracking, and evaluations.
• Reviewed R&D pipeline against new governance standards. Canceled 15% of projects.

New York City Metropolitan Area

• Recommended creation of a new, $1+ billion Women’s Health franchise (primary products were Premarin and Duavee, treatments for hot flashes, VVA and osteoporosis). Full P&L accountability. Reported to Head, North.
• Negotiated staff and operating budget to launch Duavee and gain a fresh entrée to doctors’ offices for Premarin, a product first introduced in 1942.
• Slowed Premarin revenue decline from double digits to mid-single digits and grew Duavee to $30 million in first year. Delivered forecasted results.

New York City Metropolitan Area

New York City Metropolitan Area

• Company: $1 billion, global wellness company and commercial weight management program.Challenged by CEO to develop and execute a refreshed weight loss program. Reported to Chief Scientific Officer.
• Developed and defended an evidence-based business case to completely overhaul the company’s weight loss points system.
• Created brand momentum that drove significant 2011 revenue growth.
• Awarded a patent — US8382482B2, Processes and systems for achieving and assisting in improved nutrition based on food energy data and relative healthfulness data.

Mba, Marketing

Ba, Psychology